Parkinsonism is a common clinical problem affecting the daily activities of hundreds of thousands of patients. This proposal will idnetify genes and their protein products that contribute to the etiology of this important entity. Parkinson's Disease (PD) is characterized by the specific loss of neurons in the substantia nigra. Therefore, the hypothesis of Project II: Generation and Analysis of Candidate Genes from the Substantia Nigra, is that a problem in the expression of a gene or genes in this tissue contributes to the etiology of these disorders. This will be investigated using the recently described Serial Analysis of Gene Expression (SAGE) methodology utilizing tissue from normals, PD with Lewy bodies and Frontotemporal Dementia with Parkinson's (FTDP). A unique aspect of this program project is the ability to test the specificity of the subsequently identified gene products using a genetic framework. Identified genes from this project will be used as candidate genes for Project I: The Genetics of Parkinson's Disease. The purpose of this project is to identify the gene or genes contributing to the etiology of sporadic PD. Sporadic PD patients will be investigated using new and exciting methodologies, S-TDT/SDT, looking for genetic associations in the PD patients using the SAGE and other candidate genes. It will also incorporate data from an ongoing linkage analysis of multiplex PD families. Project III: Genetic and Environmental Factors in Parkinson's Disease, continues to concentrate on dissecting the complex etiology of PD, collecting environmental data and seeking gene-environmental interaction. Three Cores will support this work: Family Ascertainment and Clinical, Neuropathological, and Statistical analysis and Informatics.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS039764-04
Application #
6529406
Study Section
Special Emphasis Panel (ZNS1-SRB-K (01))
Program Officer
Oliver, Eugene J
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
4
Fiscal Year
2002
Total Cost
$1,176,520
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Nuytemans, Karen; Maldonado, Lizmarie; Ali, Aleena et al. (2016) Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants. Neurol Genet 2:e44
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129

Showing the most recent 10 out of 114 publications